Siliq Injection
NDC Package 0187-0004-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Siliq (brodalumab) injection is a medication used to treat plaque psoriasis. This formulation utilizes a injection delivery system. Marketed by Bausch Health Us Llc, this product is identified by NDC 0187-0004 and is authorized under FDA application BLA761032.

Identification & Billing

NDC Package Code
0187-0004-03
Package Description
2 INJECTION in 1 CARTON
Product Code
0187-0004
11-Digit Billing Format
00187000403
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Siliq
Non-Proprietary Name
Brodalumab
Substance Name
Brodalumab
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
BRODALUMAB 210 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat plaque psoriasis. Brodalumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. Brodalumab treatment may lead to reduced plaque thickness, redness, and scaling.

Regulatory & Marketing

Labeler Name
Bausch Health Us Llc
Product Type
Human Prescription Drug
FDA Application #
BLA761032
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
02-15-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0187-0004). Click a package code to view its specific billing and regulatory data.

0187-0004-02
2 SYRINGE in 1 CARTON / 1 INJECTION in 1 SYRINGE (0187-0004-00)
0187-0004-04
1 INJECTION in 1 SYRINGE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0187-0004-03 identifies a specific commercial package of 2 injection in 1 carton of Siliq, a human prescription drug labeled by Bausch Health Us Llc. This injection is formulated for subcutaneous use and contains brodalumab as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us Llc on February 15, 2017. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat plaque psoriasis. Brodalumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. Brodalumab treatment may lead to reduced plaque thickness, redness, and scaling.

How is this Bausch Health Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187000403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0187-0004-03
11-Digit CMS (5-4-2)
00187-0004-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.